Pa­tient-fo­cused drug de­vel­op­ment: New FDA draft guid­ance delves in­to what’s im­por­tant

The FDA on Mon­day pub­lished the sec­ond in a se­ries of four guid­ance doc­u­ments on pa­tient-fo­cused drug de­vel­op­ment, with this lat­est draft help­ing spon­sors iden­ti­fy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER